List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 285 studies with search of: "Venous Thrombosis"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Conditions: Deep Vein Thrombosis;   Venous Thrombosis;   Postphlebitic Syndrome;   Venous Thromboembolism;   Post Thrombotic Syndrome
Intervention: Drug: Recombinant tissue plasminogen activator (rt-PA)
2 Recruiting Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto,BAY59-7939)
3 Active, not recruiting Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Deep-Vein Thrombosis Without Symptomatic Pulmonary Embolism: Einstein-DVT Evaluation
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Interventions: Drug: Xarelto (Rivaroxaban, BAY59-7939);   Drug: Enoxaparin followed by VKA
4 Not yet recruiting Cystic Fibrosis and Totally Implantable Vascular Access Devices: Evaluation of the Incidence of Venous Thrombosis Related to the Catheter and Study of the Genetic and Acquired Risk Factors
Conditions: Cystic Fibrosis;   Venous Thrombosis
Intervention: Device: totally implantable vascular access device
5 Completed Sonography Outcomes Assessment Program for Lower Extremity Deep Venous Thrombosis
Condition: Deep Venous Thrombosis
Intervention:
6 Not yet recruiting The Role of Factor XIII Activation Peptide and D-Dimer Values for the Diagnosis of Cerebral Venous Thrombosis (CVT)
Condition: Cerebral Venous Thrombosis
Intervention: Other: ELISA Test
7 Not yet recruiting Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism;   Thromboembolism;   Venous Thrombosis
Interventions: Drug: edoxaban tosylate(DU-176b);   Drug: low molecular weight heparin/unfractionated heparin;   Drug: warfarin
8 Completed Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities
Condition: Deep Venous Thrombosis
Interventions: Drug: unfractionated heparin;   Drug: Tinzaparin (Leo)
9 Completed Bioequipotency Study of SSR126517E and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs (EQUINOX)
Condition: Deep Venous Thrombosis
Intervention: Drug: SSR126517E, idraparinux, SSR29261
10 Recruiting Usefulness of Anticoagulant Treatment in First Isolated Symptomatic Calf Vein Thrombosis
Condition: Venous Thrombosis
Interventions: Drug: Nadroparine;   Drug: placebo
11 Completed Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis (ODIXa-DVT)
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Interventions: Drug: Xarelto (Rivaroxaban, BAY59-7939);   Drug: Enoxaparin/Vitamin K-Antagonist
12 Enrolling by invitation Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis
Condition: Venous Thrombosis
Intervention: Drug: 99mTc-rBitistatin
13 Recruiting Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis
Conditions: Deep Vein Thrombosis;   Cancer
Intervention: Drug: low molecular weight heparin
14 Terminated EVENT: Hydrotherapy and Deep Venous Thrombosis
Conditions: Pain;   Deep Venous Thrombosis
Interventions: Drug: thermal cure;   Drug: late thermal cure
15 Terminated Anticoagulation Post Laparoscopic Splenectomy
Conditions: Portal Vein Thrombosis;   Splenic Vein Thrombosis
Intervention: Drug: Enoxaparin
16 Not yet recruiting Ultrasound Accelerated Catheter-directed Thrombolysis in Primary Ilio-Femoral Deep Venous Thrombosis
Condition: Primary Ilio-femoral Deep Venous Thrombosis
Intervention: Device: Ekos endowave system thrombolysis
17 Completed 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE
Conditions: Deep Vein Thrombosis;   Pulmonary Embolism;   Deep Vein Thrombosis With Pulmonary Embolism
Interventions: Drug: Duration of anticoagulation;   Drug: Warfarin duration
18 Completed VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis
Conditions: Deep-Vein Thrombosis;   Pulmonary Embolism
Intervention: Drug: 5 mg folic acid, 50 mg pyridoxine and 0.4 mg cyanocobalamin
19 Completed Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation
Conditions: Cardiac Pacing;   Complications;   Venous Thrombosis
Intervention: Drug: Warfarin
20 Completed Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants
Condition: Deep Vein Thrombosis
Intervention: Drug: warfarin accordingly INR value

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services